Your browser doesn't support javascript.
loading
Unraveling the role of computed tomography derived body composition metrics on anastomotic leakages rates in rectal cancer surgery: A protocol for a systematic review and meta-analysis.
Broekman, Mark; Genders, Charlotte M S; Geitenbeek, Ritchie T J; Havenga, Klaas; Kruijff, Schelto; Klaase, Joost M; Viddeleer, Alain R; Consten, Esther C J.
Afiliação
  • Broekman M; Department of Surgery, Groningen University Medical Center, University of Groningen, Groningen, The Netherlands.
  • Genders CMS; Department of Surgery, Meander Medical Center, Amersfoort, The Netherlands.
  • Geitenbeek RTJ; Department of Surgery, Meander Medical Center, Amersfoort, The Netherlands.
  • Havenga K; Department of Surgery, Groningen University Medical Center, University of Groningen, Groningen, The Netherlands.
  • Kruijff S; Department of Surgery, Meander Medical Center, Amersfoort, The Netherlands.
  • Klaase JM; Department of Surgery, Groningen University Medical Center, University of Groningen, Groningen, The Netherlands.
  • Viddeleer AR; Department of Surgery, Groningen University Medical Center, University of Groningen, Groningen, The Netherlands.
  • Consten ECJ; Department of Surgery, Groningen University Medical Center, University of Groningen, Groningen, The Netherlands.
PLoS One ; 19(7): e0307606, 2024.
Article em En | MEDLINE | ID: mdl-39046997
ABSTRACT

INTRODUCTION:

Anastomotic leakage is a major concern following total mesorectal excision for rectal cancer, affecting oncological outcomes, morbidity an treatment costs. Body composition has been suggested to influence anastomotic leakage rates. However, literature on how body composition impact anastomotic leakage rates is conflicting. This systematic review aims to evaluate the role of computed tomography derived body composition metrics on anastomotic leakage rates in rectal cancer patients.

METHODS:

Databases PubMed/MEDLINE, Cochrane Library, web of science, and EMBASE, will be systematically searched for papers from January 2010 onwards. Study selection, data collection and quality assessment will be independently performed by three research fellows. Outcomes described in three or more studies will be included in the meta-analysis. The Q-test and I2 statistic will be used to assess statistical heterogeneity between studies. Publication bias will be examined by visual inspection of funnel plots and quantified by Egger's test. Sensitivity analyses will be conducted to examine the robustness of the meta-analysis. Reporting of the findings will be in line with the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines.

CONCLUSIONS:

This systematic review will synthesize the current evidence and will identify knowledge gaps. Results of the systematic review will aid health care professional in pre-operative decision making and will be distributed through a peer-reviewed publication and presentation of results at international meetings. TRIAL REGISTRATION PROSPERO protocol number CRD42023471537.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Composição Corporal / Tomografia Computadorizada por Raios X / Fístula Anastomótica / Revisões Sistemáticas como Assunto Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Composição Corporal / Tomografia Computadorizada por Raios X / Fístula Anastomótica / Revisões Sistemáticas como Assunto Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article